Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of temsirolimus in combination with bevacizumab in advanced endometrial, ovarian, liver, carcinoid, and pancreatic neuroendocrine cancers; trial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Gastrinoma
• Glucagonoma
• Hepatocellular Carcinoma
• Insulinoma
• Lung Carcinoid Tumor
• Ovarian Cancer
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temsirolimus (Torisel) (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-01-25